AMR Davos Compact 2025

3 Multi-Stakeholder Partnership Platform (MSPP) , and the Independent Panel for Evidence for Action against AMR. Our goal is simple: to unlock sustainable and synergistic financing from both public and private sources to reduce the global deaths associated with AMR, saving more than 100 million lives by 2050. The Unified Coalition for the AMR Response (UCARE) UCARE will start its activities under four workstream s. Innovation and Access ( Antimicrobials, Diagnostics and Vaccines) • Support the momentum for allocating adequate resources to a complementary set of access initiatives, pull incentives and push mechanisms, that revitalize the antimicrobial R&D ecosystem and expand the availability of new and existing healthcare products, while encouraging responsi ble manufacturing and disposal, across human and animal health and particularly in LMICs. • Strengthen the evidence base for the level of public and private funding required for a sustainable ant imicrobial R&D ecosystem and to deliver an effective number of high -quality innovative products to prevent, diagnose and treat the most dangerous drug -resistant infections while ensuring environmental, economic, and social sustainability. • Facilitate the creation of an international collaborative mechanism on regional and national pull incentives, based on “fair share” contributions and coordinated criteria to evaluate the value of innovative antimicrobials. • Propose and participate in the implementation of concrete solutions that address the specific market challenges which inhibit private investments in R&D and access for interventions, including treatments, diagnostics and vaccines, across all sectors, building on the experience with anti microbial therapeutics and healthcare products for other therapeutic areas (e.g., advance market commitments, subscription mechanisms, volume guarantees, etc.) . Awareness and Advocacy • Develop a high -impact creative campaign to spearhead action that reflects key learnings from campaigns such as 1.5 °C, building on the evidence from the independent science panel (once in place). • Drive awareness and advocacy through activities linked to events organized by the G7, EU, G20, G77 and bi -annual Ministerial meetings, as well as through collaborations with other